Please note
This trial is no longer recruiting patients. We hope to add results when they are available.
Breast cancer
Closed
Phase 2
This trial is looking at a new drug called lucitanib to treat breast cancer.
The trial is for women with breast cancer that has spread to another part of their body and is sensitive to the female hormone oestrogen ( or ER positive).
Recruitment start: 1 February 2014
Recruitment end: 5 August 2016
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Nick Turner
Breast International Group (BIG)
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Servier Research and Development Ltd
Last reviewed: 10 Aug 2016
CRUK internal database number: 12864
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
